GastroenterologyNews.net

Gastroenterology Xagena

Final data from IMPACT study provide proof of principle for new treatment approach. The findings confirm the biological action of the drug called MGN1703 and suggest it may be possible to identify whi ...


There are no agents specifically approved in the United States or European Union for advanced gastric cancer patients. Gastric cancer is the fourth most common cancer in the world and the second-leadi ...


PAVES ( Pegfilgrastim and Anti-VEGF Evaluation Study ) trial has evaluated Pegfilgrastim ( Neulasta ) in 845 patients receiving FOLFOX or FOLFIRI and Bevacizumab ( Avastin ) for the first-line treatme ...


The chance of ending up in a nursing facility appears to be significantly lower for older patients who undergo a laparoscopic procedure than for those who have open surgical resection for colon cancer ...


In an analysis of the results of interventions to eradicate the bacterium Helicobacter pylori ( a risk factor for gastric cancer ) in seven diverse community populations in Latin America, researchers ...


Numerous epidemiologic studies have shown that a diet high in salt is associated with an increased risk of gastric cancer. Timothy L. Cover and colleagues of Vanderbilt University have shown that high ...


In two large studies, the association between Acetylsalicylic acid ( Aspirin ) use and risk of colorectal cancer was affected by mutation of the gene BRAF, with regular Aspirin use associated with a l ...


Stem cells taken from amniotic fluid were used to restore gut structure and function following intestinal damage in rodents, in new research published in the journal Gut. The findings pave the way for ...


Intestinal bacteria may have a greater influence on us than was previously thought. In a study published in the Nature, researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden and Cha ...


A subset of colorectal cancers responds to anti-epidermal growth factor receptor ( anti-EGFR ) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR ther ...


Researchers from UCLA's Jonsson Comprehensive Cancer Center have discovered that specific types of bacteria that live in the gut are major contributors to lymphoma. Published in the journal Cancer Re ...


The human papillomavirus ( HPV ) triples the risk of people developing yet another cancer, oesophageal squamous cell carcinoma ( OSCC ), according to research led by University of New South Wales ( UN ...


The association between fibromyalgia and autoimmune diseases has been widely reported in literature. Coeliac disease is a small intestine immune-mediated disorder triggered by gluten ingestion in gene ...


Vedolizumab ( Entyvio ) is a humanized version of Act-1, a murine antibody originally developed in the 1980s with activity against the alpha4beta7-integrin heterodimer. During leukocyte extravasation ...


Takeda Pharmaceutical has announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial has evaluated Vedolizumab in 1,11 ...